Aldeyra Therapeutics (ALDX) Assets (2013 - 2026)
Aldeyra Therapeutics (ALDX) recorded Assets of $47.54 million in Q2 2026, down 44.0% from $84.96 million a year earlier and down 28.5% from the prior quarter.
Aldeyra Therapeutics (ALDX) Assets (2013 - 2026) Analysis & Trends
At the end of FY2025, Aldeyra Therapeutics reported Assets of $72.06 million, down 31.1% from FY2024.
- Annual Assets has declined for four straight years, with a five-year compound annual growth rate of -2.9% (FY2020 to FY2025).
- Across earlier years, Assets came in at $104.61 million in FY2024 (-29.5%), $148.33 million in FY2023 (-18.2%), $181.29 million in FY2022 (-22.2%) and $233.14 million in FY2021 (+179.7%).
- The Q2 2026 figure is the lowest quarterly Assets since Q3 2018.
- On a year-over-year basis, Assets has declined for 17 consecutive quarters, with an average decline of 31.7% over the last eight quarters.
- Peak year-over-year performance for Assets in the last five years was growth of 179.9% in Q3 2021, against a decline of 44.0% in Q2 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $66.48 million (Q1 2026), $72.06 million (Q4 2025) and $77.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 201.06 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Aldeyra Therapeutics | 40.82 Mn | -214.61 Mn | - | 47.54 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 47.54 Mn |
| Mar 31, 2026 | 66.48 Mn |
| Dec 31, 2025 | 72.06 Mn |
| Sep 30, 2025 | 77.80 Mn |
| Jun 30, 2025 | 84.96 Mn |
| Mar 31, 2025 | 93.20 Mn |
| Dec 31, 2024 | 104.61 Mn |
| Sep 30, 2024 | 117.32 Mn |
| Jun 30, 2024 | 126.04 Mn |
| Mar 31, 2024 | 141.30 Mn |
| Dec 31, 2023 | 148.33 Mn |
| Sep 30, 2023 | 147.28 Mn |
| Jun 30, 2023 | 155.62 Mn |
| Mar 31, 2023 | 168.22 Mn |
| Dec 31, 2022 | 181.29 Mn |
| Sep 30, 2022 | 189.69 Mn |
| Jun 30, 2022 | 201.02 Mn |
| Mar 31, 2022 | 222.69 Mn |
| Dec 31, 2021 | 233.14 Mn |
| Sep 30, 2021 | 247.22 Mn |
Aldeyra Therapeutics Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=ALDX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "ALDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=ALDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();